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Why has life expectancy recently fallen in the United States, and why is US life expectancy 
falling ever further behind that of other developed countries? In this detailed look at 
mortality by age and cause of death, Magali Barbieri quantifies the role played by the opioid 
overdose epidemic that has accompanied the stagnation or slowdown in progress for other 
causes of death, such as cardiovascular diseases.    
The decrease in life expectancy in the 
United States since 2014
In 2010, life expectancy at birth in the United States 
stopped increasing, and since 2014 it has even begun 
to fall for men. The country’s position has declined 
relative to the other OECD countries, where life 
expectancy has continued to increase (Figure 1). The 
United States started to fall behind around 1980, and 
its position has progressively deteriorated since then. 
Not only is US life expectancy lagging further and 
further behind the OECD average (excluding 
Eastern Europe), but since 2005–2006, it has even 
dropped below that of  the lowest-ranking OECD 
countries (Portugal for men and Denmark for 
women). The gap between the United States and 
Japan, the leading OECD country in terms of  life 
expectancy, is now 4.5 years for men and 5.6 years 
for women. With respect to France, the difference 
is 3 and 4 years, respectively. 
Trends that vary by age
Not all age groups are affected in the same way. Since 
2014, the year in which life expectancy at birth started 
to fall in the United States, mortality has increased at 
all ages between 20 and 60 years, with a loss of  0.20 
years of  life at these ages for both sexes combined 
(0.30 years for men and 0.06 for women). The 
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Interpretation: Each line represents trends in life expectancy at 
birth in an OECD country (apart from Mexico and Turkey due to 
lack of data, and excluding Eastern Europe) compared to the 
United States (thick red line). 
Source: Author’s calculations based on data from the Human 
Mortality Database, www.mortality.org
Figure 1. Life expectancy at birth, 1960–2017. 
United States and other OECD countries 
(excluding Eastern Europe)
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mortality increase mainly concerns men aged 20–40 
and, to a lesser extent, men aged 40–60 (Figure 2). 
Women aged 20–40 have also been affected, but much 
less severely. Mortality has continued to decline 
among young children and adults aged over 60 
(mainly those aged 80 and above), but life expectancy 
gains at these ages have been too small to fully offset 
the losses observed at other ages. 
Which causes of death have contributed to this 
trend reversal? 
Mortality from cardiovascular diseases and cancer, 
the two leading causes of  death, has fallen over the 
last decade, as have deaths from infectious diseases 
(Figure 3). The decrease in cancer mortality reflects 
the decline in smoking, which occurred earlier in 
the United States than elsewhere [1]. Cancer is the 
only major cause of  death for which mortality is 
lower in the United States than in several European 
countries, including France [2]. Progress in 
combating cardiovascular diseases, the main factor 
behind the increase in life expectancy in the 1970s 
and 1980s, has slowed down in the United States 
since the turn of  the 21st century, however, due 
notably to the increasing prevalence of  obesity and 
diabetes [3].
It is respiratory diseases (primarily among men aged 
over 60) and, above all, deaths from external causes 
(for both sexes) and the residual category of  other 
causes of  death,(1) that are driving the decline in life 
expectancy at birth in the United States. Most deaths 
from external causes are drug overdoses (classified 
as ‘poisoning’) and, to a lesser extent, suicide. These 
overdose deaths alone, referred to in the American 
media as an ‘overdose epidemic’, account for half  
of  all the years of  life lost in the general population 
between 2014 and 2017 (more than 60% among men 
aged 20–40).
The specific contribution of overdoses
Overdose mortality has increased steadily since 
around 1980, when the death rate from this cause 
was around 4 per 100,000. By 2017, the rate had 
increased to 22 per 100,000, accounting for almost 
one-third of  all deaths from external causes (which 
also include accidents, suicides, and homicides). In 
the 1990s and 2000s, the pharmaceutical industry 
launched aggressive sales campaigns encouraging 
physicians to prescribe opiate painkillers to their 
patients. Following the upsurge in unwarranted 
prescriptions, millions of  Americans became addicted. 
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(1) These ‘other diseases’ include endocrine, nutritional, and metabolic disorders; 
mental and behavioural disorders; complications of pregnancy and childbirth; 
and diseases of the nervous system. All these diseases have contributed to the 
increase in mortality since the 1980s, although no particular category stands out 
from the others.
Interpretation: The negative values correspond to the age groups in 
which mortality increased between 2014 and 2017, and the positive 
values to those in which it decreased over the same period. The 
mortality increase in the 20–39 age group has reduced life 
expectancy at birth by 0.3 years for men. This loss was partly offset 
by a gain of 0.07 years attributable to the mortality decline at ages 
80 and over. 
Source: Author’s calculations based on data from the Human 
Mortality Database,  www.mortality.org
Figure 2. Contributions of age groups to trends in 
life expectancy at birth between 2014 and 2017 
in the United States
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(a): Age-standardized death rate.
Source: Author’s calculations based on data from the Centers for 
Disease Control and Prevention.
Figure 3. Trends in causes of death 
in the United States since 1959
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Adults aged 20 to 60, and especially White low-
educated men (those without a high school diploma) 
have been most severely affected by the epidemic 
(Figure 4). In 2017, overdoses accounted for 25%–
30% of  all male deaths at ages 20–40, 20% at ages 
40–50, and slightly below 10% at ages 50–60. 
Overdose mortality at ages 60–80 has also increased, 
perhaps due to the ageing of  the birth cohorts 
affected by the upsurge in opiate addiction in the 
1990s. However, as the contribution of  other 
causes—mainly cancers and cardiovascular 
diseases—also increases steadily after age 60, the 
share of  overdose deaths in overall mortality is very 
small at advanced ages (below 2%). 
When the US government responded to this crisis in 
the early 2010s by restricting access to prescription 
opioids, addicts turned to the black market, which 
has been inundated since 2013 by new-generation 
drugs such as fentanyl, an extremely potent synthetic 
molecule, much cheaper to produce than heroin or 
cocaine. Consequently, illicit consumption of  all 
these opioids skyrocketed, leading to a new upsurge 
in overdose deaths, which doubled over the period 
2010–2017. The death toll from opioid abuse reached 
70,000 in 2017, more than that of  traffic accidents, 
suicides, homicides, and HIV-AIDS combined. The 
epidemic has now spread to all American states. 
Geographical disparities in mortality
The overdose epidemic began among economically 
disadvantaged populations where the proportion 
of  people in poor self-rated health and reporting 
chronic pain has increased steadily in surveys since 
t h e  1 9 9 0 s  [ 4 ] .  T h e s e 
populations are concentrated 
in the south-west of  the 
country, but also, and above 
all, in its former industrial 
heartlands to the south and 
east of  the Great Lakes. It is 
in these regions ravaged by 
the recession of  the late 2000s 
that  the  phar maceut ica l 
companies  focused their 
marketing campaigns [5]. The 
epidemic then spread across 
the entire country, affecting 
life expectancy everywhere. 
Between 2014 and 2016, there 
were only four US states in 
which life expectancy at birth 
continued to increase for both 
sexes :  Louis iana ,  Texas, 
Washington, and Wyoming. 
In all others, it fell for men, for women, or for both 
sexes. The life expectancy downturn was especially 
pronounced in the north-east of  the United States 
and in Alaska. The rapid rise in overdose mortality 
was independent of  the initial mortality level, 
affecting states such as New Hampshire, which 
topped the ranking for life expectancy at birth in 
2010 (the year when progress halted at national 
level), as well as those at the bottom, such as West 
Virginia, where overdose mortality is at its highest 
(Figure 5).
Conscious of  the gravity of  the situation, the US 
authorities have implemented a whole series of  
measures designed to contain and curb the epidemic. 
They include programmes to stop the most toxic 
products from entering the country (across the 
borders or through the mail), to promote the use of  
naloxone, an effective fentanyl antidote, to increase 
the number of  rehabilitation centres for addicts, and 
to facilitate access to treatment [6]. It is still too soon 
to assess their impact on overdose mortality. Even if  
successful, they are unlikely to produce a rapid 
improvement in life expectancy at birth, given the 
weak public policy response to the other factors 
underlying the current lack of  progress (e.g. poor 
eating habits). In a context of  increasing mortality 
from causes other than those linked to drug abuse, 
and of  a slower decrease in mortality from 
cardiovascular diseases, there is little chance that the 
United States will catch up with the countries of  
Western and Northern Europe or Japan over the 
short term [2].
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Source: Author’s calculations based on data from the Centers for Disease Control and Prevention.
Figure 4. Overdose mortality rate by sex and age group, 
1980–2017
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[6] A. L. Pitt, K. Humphreys and M. L. Brandeau, 2018, 
“Modeling health benefits and harms of public policy res-
ponses to the US opioid epidemic”, American Journal of 
Public Health, 108(10), 1394–1400.
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Keywords
Life expectancy at birth in the United States stopped 
increasing in 2010 and has even been declining for men 
since 2014. The United States started to fall behind other 
countries around 1980, and its ranking has fallen steadily 
since then. Progress in combating cardiovascular diseases, 
the main factor behind the increase in life expectancy in 
the 1970s and 1980s, has slowed since 2000, due notably 
to the increase in obesity and diabetes. The drug overdose 
epidemic accounts for half of the years of life lost between 
2014 and 2017. Overdose mortality increased more than 
fivefold between 1980 and 2017.
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Source: Map produced by the author based on data from the Centers for Disease Control and Prevention.
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Figure 5. Age-standardized overdose mortality rate, both sexes combined, 2017
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